← Back to Search

Neuromodulator

AbobotulinumtoxinA for Cosmetic Procedures (JBDX Trial)

N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 3, day 30, day 90, day 180
Awards & highlights

JBDX Trial Summary

This trial is testing the effects of 4 different neuromodulators on wrinkles and lines on the face, using 3D imaging. Women who have not had any cosmetic procedures on their face in the last year and have not used neuromodulators in the last 12 months are eligible to participate.

JBDX Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 3, day 30, day 90, day 180
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 3, day 30, day 90, day 180 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
the change in dynamic strain in the glabella area after injection over time
Secondary outcome measures
assess patient reported satisfaction (FACE-Q) to the degree of dynamic strain overtime
the change in dynamic strain in the glabella area after injections over time between two facial animations

JBDX Trial Design

4Treatment groups
Active Control
Group I: AbobotulinumtoxinAActive Control1 Intervention
Dysport
Group II: OnabotulinumtoxinAActive Control1 Intervention
Botox
Group III: PrabotulinumtoxinAActive Control1 Intervention
Jeuveau
Group IV: IncobotulinumtoxinAActive Control1 Intervention
Xeomin

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,945 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has IncobotulinumtoxinA been the subject of other research initiatives?

"Currently, 61 studies are in progress regarding the effects of IncobotulinumtoxinA with 20 trials currently at Phase 3. This research is taking place across 759 sites, many located in Farmington Hills, Michigan."

Answered by AI

In what cases is IncobotulinumtoxinA typically prescribed?

"IncobotulinumtoxinA is the most commonly prescribed treatment for urinary incontinence. This drug has demonstrated success in treating a variety of other afflictions, including spinal cord injuries, botox injections and overactive bladder syndrome (OABs)."

Answered by AI

Is the opportunity to participate in this research experiment available at present?

"Yes, according to the data hosted on clinicaltrials.gov this research endeavour is actively searching for suitable participants. The trial was initially listed online on March 4th 2022 and has been updated as recently as June 27th 2022."

Answered by AI

Does the trial include geriatric participants?

"This medical research adheres to a set of inclusion criteria which stipulates that participants must be between the ages of 30 and 65."

Answered by AI

Who is the ideal participant for this clinical investigation?

"The trial seeks to enrol 140 participants aged between 30 and 65 who have already undergone some kind of cosmetic intervention. To be eligible, these patients must also express a desire for glabellar injections--used to reduce wrinkles and facial stressors--and identify as female."

Answered by AI

How many test subjects are engaged in this research?

"Affirmative. According to the information available on clinicaltrials.gov, this medical research is presently recruiting volunteers; it was posted on March 4th 2022 and most recently updated June 27th of that same year. In total, 140 people are needed from one location for participation in the trial."

Answered by AI

Who else is applying?

What state do they live in?
Virginia
Other
New Jersey
South Carolina
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
Penn Medicine
How many prior treatments have patients received?
2
0

What questions have other patients asked about this trial?

Please let me know what you think?
PatientReceived 2+ prior treatments

Why did patients apply to this trial?

To help with the wrinkles in my face, improve confidence. I’m hoping this clinical trial will address the wrinkles inherited from the Sun or bad skin or aging.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area
2022. "Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05167864.
~46 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top